Capital Management Associates Inc’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$668K Hold
15,654
0.13% 87
2026
Q1
$982K Hold
15,654
0.22% 63
2025
Q4
$1.49M Hold
15,654
0.33% 46
2025
Q3
$1.53M Hold
15,654
0.41% 38
2025
Q2
$1.68M Sell
15,654
-15,654
-50% -$1.58M 0.53% 29
2025
Q1
$3.16M Buy
31,308
+15,654
+100% +$1.58M 0.72% 23
2024
Q4
$1.4M Hold
15,654
0.52% 31
2024
Q3
$1.31M Hold
15,654
0.54% 30
2024
Q2
$1.21M Sell
15,654
-40,402
-72% -$2.96M 0.73% 24
2024
Q1
$3.84M Buy
56,056
+40,402
+258% +$2.6M 2.83% 10
2023
Q4
$905K Buy
+15,654
New +$836K 0.53% 30

Other funds holding BSX

Capital Management Associates Inc's BSX Position: Q2 2026 in Review

Capital Management Associates Inc held its Boston Scientific (BSX) position steady in Q2 2026 at 15,654 shares worth $668K. The position accounts for 0.13% of the portfolio, ranked #87.

Capital Management Associates Inc first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.84M in Q1 2024. 536 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Capital Management Associates Inc held 15,654 shares of Boston Scientific worth $668K as of Q2 2026.
  • Capital Management Associates Inc left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.13% of Capital Management Associates Inc's portfolio in Q2 2026, its #87 holding.
  • Capital Management Associates Inc first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Capital Management Associates Inc's Boston Scientific position peaked at $3.84M in Q1 2024.
  • 536 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Capital Management Associates Inc's 13F filing for Q2 2026, filed 22 Jul 2026.